Gainers
-
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)
rose 22.1 percent to $6.03 in pre-market trading after announcing the FDA approval of RELISTOR tablets for the treatment of
opioid-induced constipation in adults with chronic non-cancer pain.
-
Towerstream Corporation (NASDAQ: TWER) shares
rose 17.1 percent to $3.76 in pre-market trading after surging 29.44 percent on Tuesday. Towerstream is scheduled to report Q2
financial results on August 9, 2016.
-
TerraForm Global Inc (NASDAQ: GLBL) shares rose
15.4 percent to $3.75 in pre-market trading. TerraForm Global reported preliminary unaudited financial information for the
second half of 2015 and first quarter of 2016. Terraform Global Inc reported that SunEdison Inc is planning to sell its
interest in the Terraform.
-
Intuitive Surgical, Inc. (NASDAQ: ISRG) rose 6.7
percent to $717.14 in pre-market trading after the company posted stronger-than-expected results for the second quarter on
Tuesday.
-
Microsoft Corporation (NASDAQ: MSFT) shares rose
5.1 percent to $55.78 in pre-market trading after the company reported better-than-expected fiscal fourth-quarter financial
results on Tuesday.
-
Cerulean Pharma Inc (NASDAQ: CERU) shares rose
4.7 percent to $3.10 in pre-market trading after gaining 29.82 percent on Tuesday.
-
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) rose
4.5 percent to $24.60 in pre-market trading as the company reported that the FDA has approved RELISTOR tablets for the
treatment of opioid-induced constipation in adults with chronic non-cancer pain.
-
Cintas Corporation (NASDAQ: CTAS) rose 4.2
percent to $101.50 in pre-market trading after the company reported upbeat Q4 results and issued a strong FY forecast.
-
Morgan Stanley (NYSE: MS) rose 3.2 percent to $29.09
in the pre-market trading session after the bank announced better-than-expected adjusted earnings and revenue for the second
quarter.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Zafgen Inc (NASDAQ: ZFGN) shares fell 43.7
percent to $3.80 in the pre-market trading session after the company reported that it has suspended the development of its
obesity drug Beloranib.
-
Exponent, Inc. (NASDAQ: EXPO) shares fell 15.1
percent to $49.59 in pre-market trading after the company reported downbeat Q2 results.
-
Skypeople Fruit Juice Inc (NASDAQ: SPU) fell 6.4
percent to $5.88 in pre-market trading after climbing 12.95 percent on Tuesday.
-
Ryerson Holding Corp (NYSE: RYI) shares fell 4.6
percent to $15.52 in pre-market trading. Ryerson priced its 5 million share offering at $15.25 per share.
-
Tenaris SA (ADR) (NYSE: TS) shares fell 3.7 percent
to $26.63 in pre-market trading. Goldman Sachs downgraded Tenaris from Buy to Neutral.
-
Monroe Capital Corp (NASDAQ: MRCC) shares fell
3.5 percent to $15.36 in pre-market trading. Monroe Capital reported a public offering of common shares.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.